Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus

Introduction: Adjunctive therapy with polyclonal intravenous immunoglobins (IVIg) is currently used for preventing or managing infections and sepsis, especially in immunocompromised patients. The pathobiology of COVID-19 and the mechanisms of action of Ig led to the consideration of this adjunctive...

Descripción completa

Detalles Bibliográficos
Autores principales: Coloretti, Irene, Berlot, Giorgio, Busani, Stefano, De Rosa, Francesco Giuseppe, Donati, Abele, Forfori, Francesco, Grasselli, Giacomo, Mirabella, Lucia, Tascini, Carlo, Viale, Pierluigi, Girardis, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396919/
https://www.ncbi.nlm.nih.gov/pubmed/34441796
http://dx.doi.org/10.3390/jcm10163500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396919/
https://www.ncbi.nlm.nih.gov/pubmed/34441796
http://dx.doi.org/10.3390/jcm10163500

Ejemplares similares